loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Standard Chem. & Pharm. Co., Ltd

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Acyclovir (1)

02 Anastrozole (1)

03 Aripiprazole (1)

04 Bicalutamide (1)

05 Bisacodyl (1)

06 Calcium Acetate (1)

07 Capecitabine (1)

08 Captopril (1)

09 Carbinoxamine (1)

10 Cyclophosphamide (1)

11 Cyproheptadine (1)

12 Dasatinib (1)

13 Erlotinib (1)

14 Glycopyrrolate (1)

15 IMATINIB MESYLATE (1)

16 Letrozole (1)

17 Mefenamic Acid (1)

18 Mercaptopurina (1)

19 Methotrexate (1)

20 Nilutamide (1)

21 Repaglinide (1)

22 Selegiline (1)

23 Sorafenib (1)

24 Temozolomide (1)

filter

01 Stason Pharmaceuticals, Inc. (24)

filter

01 U.S.A (24)

URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high conta...
Headquartered in Southern California, Stason entered the commercial generic market in 1994 and today continues to manufacture and market these products through our global network of distributors. Stason entered the contract manufacturing arena in 2000 to provide manufacturing support to other pharmaceutical companies. We provide both non-high containment and high containment manufacturing services. In 2008, we launched our Brand Division when we obtained exclusive development and commercialization rights to two novel proprietary compounds in the area of oncology.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY